The Orbital Fibroblast: A Key Player and Target for Therapy in Graves' Ophthalmopathy

被引:29
|
作者
van Steensel, Leendert [1 ]
Dik, Willem A. [1 ]
机构
[1] Erasmus MC, Dept Immunol, POB 2040, NL-3000 CA Rotterdam, Netherlands
来源
ORBIT-AN INTERNATIONAL JOURNAL ON ORBITAL DISORDERS AND FACIAL RECONSTRUCTIVE SURGERY | 2010年 / 29卷 / 04期
关键词
Graves' Ophthalmopathy; Orbital fibroblast; PDGF; Therapy; Pathogenesis;
D O I
10.3109/01676831003668443
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Orbital fibroblasts play a key role in the pathogenesis of Graves' ophthalmopathy (GO). We discuss some major aspects by which orbital fibroblasts contribute to GO and the important role of PDGF-BB herein. Finally, we propose the orbital fibroblast, and especially the PDGF system acting on orbital fibroblasts, as an important therapeutic target in GO.
引用
收藏
页码:202 / 206
页数:5
相关论文
共 50 条
  • [41] Superior orbital fissure syndrome after deep lateral orbital wall decompression in Graves' ophthalmopathy
    Bengoa-Gonzalez, Alvaro
    Lago-Llinas, Maria-Dolores
    Mencia-Gutierrez, Enrique
    Salvador, Elena
    ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2024, 43 (04): : 439 - 447
  • [42] The impact of 99mTc-DTPA orbital SPECT in patient selection for external radiation therapy in Graves' ophthalmopathy
    Szabados, Lajos
    Nagy, Endre V.
    Ujhelyi, Bernadett
    Urbancsek, Hilda
    Varga, Jozsef
    Nagy, Edit
    Galuska, Laszlo
    NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (02) : 108 - 112
  • [43] Intravenous methylprednisolone pulse therapy in the treatment of Graves' ophthalmopathy
    Matejka, G
    Vergès, B
    Vaillant, G
    Petit, JM
    Brun-Pacaud, A
    Rudoni, S
    Brun, JM
    HORMONE AND METABOLIC RESEARCH, 1998, 30 (02) : 93 - 98
  • [44] Comparative analysis of dosimetric parameters of three different radiation techniques for patients with Graves' ophthalmopathy treated with retro-orbital irradiation
    Lee, Victor H. F.
    Ng, Sherry C. Y.
    Choi, Cheuk Wai
    Luk, Mai Yee
    Leung, To Wai
    Au, Gordon K. H.
    Kwong, Dora L. W.
    RADIATION ONCOLOGY, 2012, 7
  • [45] Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
    Le Moli, Rosario
    Malandrino, Pasqualino
    Russo, Marco
    Lo Giudice, Fabrizio
    Frasca, Francesco
    Belfiore, Antonino
    Vigneri, Riccardo
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [46] TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves’ ophthalmopathy
    R. S. Bahn
    Journal of Endocrinological Investigation, 2004, 27 : 216 - 220
  • [47] Evaluation of quality of life in patients with Graves' ophthalmopathy, before and after orbital decompression
    Iacobaeus, Lykke
    Sahlin, Sven
    ORBIT-AN INTERNATIONAL JOURNAL ON ORBITAL DISORDERS AND FACIAL RECONSTRUCTIVE SURGERY, 2016, 35 (03): : 121 - 125
  • [48] Balancing orbital volume reduction and redistribution for a tailored surgical treatment in Graves’ ophthalmopathy
    Victor Vlad Costan
    Constantin-Catalin Ciocan-Pendefunda
    Mihai Liviu Ciofu
    Otilia Boisteanu
    Daniel Vasile Timofte
    Liliana Gheorghe
    Camelia Bogdanici
    Cristina Preda
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 : 2313 - 2320
  • [49] Relation between therapy options for Graves' disease and the course of Graves' ophthalmopathy: a systematic review and meta-analysis
    Li, H. X.
    Xiang, N.
    Hu, W. K.
    Jiao, X. L.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (11) : 1225 - 1233
  • [50] Interleukin-7 expression in tears and orbital tissues of patients with Graves’ ophthalmopathy
    KeBo Cai
    RuiLi Wei
    Endocrine, 2013, 44 : 140 - 144